|
DK2006381T3
(en)
|
2006-03-31 |
2016-02-22 |
Chugai Pharmaceutical Co Ltd |
PROCEDURE FOR REGULATING ANTIBODIES BLOOD PHARMACOKINETICS
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
DK2202245T3
(en)
|
2007-09-26 |
2016-11-21 |
Chugai Pharmaceutical Co Ltd |
A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR
|
|
PT2708559T
(pt)
|
2008-04-11 |
2018-05-16 |
Chugai Pharmaceutical Co Ltd |
Molécula de ligação ao antigénio capaz de se ligar repetidamente a duas ou mais moléculas de antigénio
|
|
WO2012061448A1
(en)
|
2010-11-04 |
2012-05-10 |
Boehringer Ingelheim International Gmbh |
Anti-il-23 antibodies
|
|
MX365235B
(es)
|
2010-11-30 |
2019-05-28 |
Chugai Pharmaceutical Co Ltd |
Molécula de unión a antígeno capaz de unir repetidamente a la pluralidad de moléculas de antígeno.
|
|
CN103796667A
(zh)
|
2011-06-22 |
2014-05-14 |
艾普莱斯制药公司 |
用补体抑制剂治疗慢性障碍的方法
|
|
RU2013158256A
(ru)
|
2011-07-06 |
2015-07-10 |
Нестек С.А. |
АНАЛИЗЫ ДЛЯ ОБНАРУЖЕНИЯ НЕЙТРАЛИЗУЮЩИХ АУТОАНТИТЕЛ ДЛЯ БИОЛОГИЧЕСКОЙ ТЕРАПИИ TNFα
|
|
EP2583979B1
(en)
|
2011-10-19 |
2015-12-16 |
Effimune |
Methods to prepare antibodies directed against p19 subunit of human IL-23
|
|
US11078265B2
(en)
|
2012-05-03 |
2021-08-03 |
Boehringer Ingelheim International Gmbh |
Anti-IL-23 antibodies
|
|
SG11201408161RA
(en)
*
|
2012-06-08 |
2015-01-29 |
Sutro Biopharma Inc |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP3135690A1
(en)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
|
TWI855488B
(zh)
|
2012-08-24 |
2024-09-11 |
日商中外製藥股份有限公司 |
FcγRIIb特異性Fc區域變異體
|
|
WO2014030750A1
(ja)
|
2012-08-24 |
2014-02-27 |
中外製薬株式会社 |
マウスFcγRII特異的Fc抗体
|
|
ES2728864T3
(es)
|
2012-08-31 |
2019-10-29 |
Sutro Biopharma Inc |
Aminoácidos modificados que comprenden un grupo azido
|
|
BR112015006368B1
(pt)
*
|
2012-09-24 |
2022-02-08 |
Medimmune Limited |
Processo para produção de linha celular eucariótica estável
|
|
BR112015022641B1
(pt)
|
2013-03-15 |
2023-02-28 |
Medimmune Limited |
Construção de dna e processo de preparação de uma proteína-alvo
|
|
SG11201508170TA
(en)
|
2013-04-02 |
2015-11-27 |
Chugai Pharmaceutical Co Ltd |
Fc REGION VARIANT
|
|
ES2658039T3
(es)
*
|
2013-07-10 |
2018-03-08 |
Sutro Biopharma, Inc. |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
|
JP6571650B2
(ja)
|
2013-08-05 |
2019-09-04 |
メディミューン リミテッド |
アミノ酸誘導体
|
|
JP6687247B2
(ja)
|
2014-05-10 |
2020-04-22 |
ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
化学的に固定された二重特異性抗体
|
|
WO2016014775A1
(en)
|
2014-07-24 |
2016-01-28 |
Boehringer Ingelheim International Gmbh |
Biomarkers useful in the treatment of il-23a related diseases
|
|
WO2016036918A1
(en)
|
2014-09-03 |
2016-03-10 |
Boehringer Ingelheim International Gmbh |
Compound targeting il-23a and tnf-alpha and uses thereof
|
|
ES2735085T3
(es)
*
|
2014-12-05 |
2019-12-16 |
Nestle Sa |
Ensayos de cambio de movilidad homogéneos indirectos para la detección de agentes biológicos en muestras de pacientes
|
|
MX2017005774A
(es)
|
2014-12-19 |
2017-07-28 |
Chugai Pharmaceutical Co Ltd |
Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
|
|
BR112017014684A2
(en)
|
2015-02-04 |
2018-01-09 |
Boehringer Ingelheim International Gmbh |
methods of treatment of inflammatory diseases
|
|
SG11201706014PA
(en)
|
2015-02-05 |
2017-08-30 |
Chugai Pharmaceutical Co Ltd |
Antibodies comprising an ion concentration dependent antigen-binding domain, fc region variants, il-8-binding antibodies, and uses therof
|
|
US10709839B2
(en)
|
2015-03-04 |
2020-07-14 |
Repro-Med Systems, Inc. |
Precision variable flow rate infusion system and method
|
|
JP6967221B2
(ja)
|
2015-08-19 |
2021-11-17 |
国立研究開発法人理化学研究所 |
非天然アミノ酸導入抗体
|
|
JP7141336B2
(ja)
|
2015-12-25 |
2022-09-22 |
中外製薬株式会社 |
抗ミオスタチン抗体および使用方法
|
|
CN106924753B
(zh)
*
|
2015-12-30 |
2021-11-09 |
北京大学 |
制备蛋白质-聚氨基酸环状偶联物的方法
|
|
US11708413B2
(en)
|
2016-01-27 |
2023-07-25 |
Sutro Biopharma, Inc. |
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
|
|
KR102538749B1
(ko)
|
2016-08-05 |
2023-06-01 |
추가이 세이야쿠 가부시키가이샤 |
Il-8 관련 질환의 치료용 또는 예방용 조성물
|
|
MY201744A
(en)
*
|
2016-12-23 |
2024-03-15 |
Visterra Inc |
Binding polypeptides and methods of making the same
|
|
JP7265788B2
(ja)
*
|
2017-05-09 |
2023-04-27 |
シアノ バイオテック ゲーエムベーハー |
修飾ミクロシスチンおよびノジュラリン
|
|
AU2018347704A1
(en)
|
2017-10-13 |
2020-05-28 |
Ursure, Inc. |
Products and methods for monitoring adherence to nucleoside reverse transcriptase inhibitor therapy
|
|
CN110283249A
(zh)
*
|
2018-03-19 |
2019-09-27 |
江苏莱博德医疗科技有限公司 |
一种抗白介素6的人ScFv单链抗体
|
|
US20190292310A1
(en)
*
|
2018-03-20 |
2019-09-26 |
Northeastern University |
Synthesis of high density molecular dna brushes via organic-phase ring-opening metathesis (co)polymerization
|
|
US11440967B2
(en)
|
2018-05-31 |
2022-09-13 |
Glyconex Inc. |
Therapeutic antibodies
|
|
MX2021003976A
(es)
*
|
2018-10-11 |
2021-05-27 |
Amgen Inc |
Procesamiento posterior de constructos de anticuerpos biespecificos.
|
|
US20200405883A1
(en)
|
2019-06-20 |
2020-12-31 |
Baxalta Incorporated |
Method of treatment with viral-based gene therapy
|
|
CN113203863B
(zh)
*
|
2021-04-28 |
2022-01-21 |
北京美联泰科生物技术有限公司 |
一种适用于白介素-6检测的缓冲液
|
|
CN113150122B
(zh)
*
|
2021-05-19 |
2023-03-17 |
上海儒克生物科技有限公司 |
高通量全兔源单克隆抗体的制备方法
|
|
AU2022280767A1
(en)
|
2021-05-24 |
2024-01-18 |
Humabs Biomed Sa |
Engineered polypeptides
|
|
CN115957319B
(zh)
*
|
2022-10-14 |
2023-06-30 |
北京东方百泰生物科技股份有限公司 |
一种抗nkg2a单克隆抗体的注射制剂
|
|
WO2025010424A1
(en)
|
2023-07-06 |
2025-01-09 |
Vir Biotechnology, Inc. |
Antibodies against staphylococcus antigens and methods of using the same
|
|
PL448731A1
(pl)
*
|
2024-05-31 |
2025-12-01 |
Celon Pharma Spółka Akcyjna |
Przeciwciała bispecyficzne anty–IL-17A i anty-IL-6 oraz ich zastosowanie w terapii, zwłaszcza w leczeniu chorób immunologicznych
|
|
CN120329434B
(zh)
*
|
2025-06-23 |
2025-10-21 |
杭州市第一人民医院(西湖大学附属杭州市第一人民医院) |
一种mfge8单克隆抗体及其制备方法和应用
|